A Prostate Cancer Prevention Pill Looks Safer
Sign In
HOME
ABOUT US
CONTACT
SUBSCRIBERS
ARCHIVE
Search
By Ingfei Chen
A Prostate Cancer Prevention Pill Looks Safer
Yet questions remain about finasteride's true long-term risks and benefits
By Ingfei Chen
It seemed a Faustian deal: In 2003, the $73 million Prostate Cancer Prevention Trial (PCPT) found that a pill called Proscar (finasteride) cut the incidence of prostate tumors—mainly the slow-growing, low-grade types—by almost 25 percent. But it also slightly boosted the incidence of the deadliest prostate cancers.
Last September, ...
To view the complete article, please log in. Your subscriber ID is located on your mailing label and begins with the letters CA.
Subscriber ID
ZIP Code
Back to Winter 2008
Fall 2010
Spring / Summer 2010
Winter 2010
Fall 2009
Summer 2009
Spring 2009
Winter 2009
Cancer Prevention 2008
Fall 2008
Summer 2008
Spring 2008
Breast Cancer 2008
Winter 2008
Fall 2007
Summer 2007
Spring 2007
Winter 2007
Fall 2006
Summer 2006
Spring 2006
CR Podcasts
Online Exclusives
CR Reports From SABCS 2008
CR Reports From SABCS 2009